Related Experiment Video
Updated: Jun 27, 2026
08:43
Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation
Published on: May 31, 2016
Atherosclerotic plaque development and instability: a dual role for VEGF
Pieter W Holm1, Riemer H J A Slart, Clark J Zeebregts
1Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Annals of Medicine
|December 18, 2008
Summary
Vascular endothelial growth factor (VEGF) plays a dual role in vascular health. While crucial for blood vessel integrity, it may also promote atherosclerotic plaque formation and instability.
Area of Science:
- Cardiovascular Biology
- Angiogenesis Research
- Atherosclerosis Pathophysiology
Background:
- Vascular endothelial growth factor (VEGF) is essential for endothelial cell function and angiogenesis.
- Endothelial integrity is vital for maintaining vascular health.
- VEGF's role in atherosclerosis is complex and warrants further investigation.
Purpose of the Study:
- To review the current literature on VEGF's role in vulnerable atherosclerotic plaques.
- To explore VEGF's function as an angiogenic and inflammatory cytokine in this context.
Main Methods:
- Literature review of existing studies on VEGF and atherosclerosis.
- Analysis of data concerning VEGF's angiogenic and inflammatory properties.
Main Results:
- VEGF is a key factor in endothelial cell growth and new blood vessel formation (angiogenesis).
- VEGF can contribute to the development and destabilization of atherosclerotic plaques.
- Evidence suggests VEGF acts as both an angiogenic and inflammatory cytokine in vulnerable plaques.
Conclusions:
- VEGF has a dichotomous role in vascular disease, supporting integrity but potentially driving plaque pathology.
- Understanding VEGF's specific functions in vulnerable atherosclerotic plaques is critical for developing targeted therapies.
Related Concept Videos
01:30Atherosclerosis I: Introduction
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
01:24Regulation of Angiogenesis and Blood Supply
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
01:26Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
01:10Mechanism of Angiogenesis
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
01:38Inflammation
Overview
01:16Clot Retraction and Fibrinolysis
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.